Product Description

Hemlibra 150mg/0.7ml Injection consists of the active ingredient Emicizumab. It is indicated to treat Haemophilia A. Heamophilia A is a genetic bleeding condition caused by a lack of factor VIII, which is essential factor for blood clotting.|

The liver synthesizes factor VIII. Its deficiency affects one in ten thousand individuals. This can lead to bleeding disorder and in severe cases, bleeding may occur in your skin, muscle and joints. Frequent bleeding, especially in the joints, alters the physical and mental well-being of the patients and caregivers.

How to use

Hemlibra 150mg/0.7ml Injection will be given to you by a physician qualified for treating haemophilia. Your physician will educate you on how to use this medicine.

Uses

Treatment of control of bleeding in patients with Hemophilia A

Side Effects

Serious:

• Confusion, weakness, swelling of arms and legs
• Yellow skin and eyes
• Stomach or back pain
• Nausea, vomiting
• Decreased urination

Common:

• Fever
• Muscle pain
• Diarrhea
• Headache

Storage

Do not freeze,Store in a refrigerator 2 - 8℃